Cetrorelix
Cetrotide (cetrorelix) is a protein pharmaceutical. Cetrorelix was first approved as Cetrotide on 1999-04-12. It is used to treat ovarian hyperstimulation syndrome in the USA. It has been approved in Europe to treat ovulation and ovulation induction. The pharmaceutical is active against gonadotropin-releasing hormone receptor.
| Trade Name | Cetrotide |
|---|---|
| Common Name | Cetrorelix |
| Indication | ovarian hyperstimulation syndrome, ovulation, ovulation induction |
| Drug Class | Hormone-release inhibiting peptides |
